Wells Fargo’s Monopar Therapeutics MNPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $82.3K | Buy |
2,301
+2,051
| +820% | +$73.4K | ﹤0.01% | 4896 |
|
|
2025
Q1 | $9.1K | Hold |
250
| – | – | ﹤0.01% | 5437 |
|
|
2024
Q4 | $5.5K | Sell |
250
-250
| -50% | -$5.5K | ﹤0.01% | 5543 |
|
|
2024
Q3 | $3.37K | Hold |
500
| – | – | ﹤0.01% | 5582 |
|
|
2024
Q2 | $1.83K | Buy |
500
+193
| +63% | +$704 | ﹤0.01% | 5645 |
|
|
2024
Q1 | $1.05K | Buy |
307
+300
| +4,286% | +$1.02K | ﹤0.01% | 5746 |
|
|
2023
Q4 | $13 | Hold |
7
| – | – | ﹤0.01% | 6885 |
|
|
2023
Q3 | $20 | Hold |
7
| – | – | ﹤0.01% | 6825 |
|
|
2023
Q2 | $28 | Buy |
7
+1
| +17% | +$4 | ﹤0.01% | 6903 |
|
|
2023
Q1 | $43 | Hold |
6
| – | – | ﹤0.01% | 6825 |
|
|
2022
Q4 | $73 | Hold |
6
| – | – | ﹤0.01% | 6554 |
|
|
2022
Q3 | $0 | Hold |
6
| – | – | ﹤0.01% | 6769 |
|
|
2022
Q2 | $0 | Buy |
6
+1
| +20% | – | ﹤0.01% | 6920 |
|
|
2022
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 7017 |
|
|
2021
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 7008 |
|
|
2021
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 6940 |
|
|
2021
Q2 | $0 | Buy |
5
+1
| +25% | – | ﹤0.01% | 6842 |
|
|
2021
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 6779 |
|
|
2020
Q4 | $0 | Buy |
4
+1
| +33% | – | ﹤0.01% | 6431 |
|
|
2020
Q3 | $0 | Buy |
+3
| New | – | ﹤0.01% | 6268 |
|